ICU Equipment

Sentec AG manufactures noninvasive monitoring solutions for critical care, intensive care, and neonatal settings. The company specializes in transcutaneous monitoring (TCM) technology that enables continuous, accurate measurement of blood gases without invasive arterial puncture, supporting ventilation titration and weaning protocols. Sentec's product portfolio includes the IPV® 1 (Intrapulmonary Percussive Ventilation), a portable, lightweight respiratory therapy device with simplified clinical interfaces; and the LuMon™ System, which uses Electrical Impedance Tomography (EIT) for real-time, noninvasive visualization of regional lung function at the bedside with automatic patient position tracking. The company emphasizes reducing painful procedures in vulnerable populations, particularly neonates in the NICU, by minimizing the need for frequent blood draws while maintaining clinical accuracy. Sentec maintains a global distribution network with regional customer service offices across North America, Europe, Australia, and Asia-Pacific. The company adheres to medical device quality standards and regulatory requirements appropriate to its markets. Products are designed for hospital ICUs, NICUs, and acute care settings where continuous respiratory and gas monitoring inform clinical decision-making and patient safety protocols.

CytoSorbents, Inc. is a medical technology company specializing in hemoadsorption blood purification therapy. The company develops extracorporeal adsorption devices based on proprietary biocompatible polymer bead technology designed to reduce elevated levels of potentially harmful compounds from whole blood. The primary product, CytoSorb 300®, is an adsorber that complements conventional dialysis approaches and is used in critical care, cardiovascular, liver, and kidney therapeutic areas. CytoSorbents also offers PuriFi, an independent therapy platform enabling standalone CytoSorb® use; ECOS-300CY for ex vivo organ perfusion applications; and VetResQ for veterinary critical-care applications. The company maintains a global presence in over 75 countries and provides clinical support through a team of specialists. Products are CE-marked and available internationally, though CytoSorb 300® and related human therapeutics are not authorized or cleared in the US market. VetResQ is available only in the US. The company positions itself as a trusted partner for advanced blood purification technologies in settings where physiological balance and management of inflammatory or harmful substances is critical.

Belun Technology designs and manufactures medical-grade wearable devices and AI-powered software platforms for sleep health monitoring, home sleep apnea testing, and remote patient vital signs monitoring. The company's core offerings include the Belun® Ring, an FDA 510(k)-cleared wearable device that performs home sleep apnea screening and monitors sleep health using clinically validated algorithms, and the Belun® remoVital system, a real-time remote vital signs monitoring solution comprising the Belun® Ring, Belun® COR (body temperature sensor), and a communication hub. The remoVital system measures blood oxygen saturation, pulse rate, and body temperature, with alert functionality designed to enable early detection of clinical deterioration and support timely medical intervention. Products target both consumers seeking self-managed wellness monitoring and healthcare professionals requiring scalable remote monitoring solutions for clinical accuracy and care quality improvement. The company emphasizes medical-grade accuracy, ease of use, and affordability. Belun holds FDA 510(k) clearance for its sleep monitoring and vital signs monitoring systems. The platform employs proprietary AI algorithms for predictive analytics and personalized care delivery. Markets served include home-based sleep apnea screening, remote patient monitoring in residential care facilities, and integrated telehealth/remote care workflows. The company has received strategic investment from IHH Healthcare and Gravity Capital Partners, indicating growth in global expansion and product development.

Patient Shield Concepts LLC manufactures SuctionShield, a disposable, single-patient suction holster designed to prevent healthcare-associated infections (HAIs) in critical care settings. SuctionShield holds Yankauer suction tips and other oral suction implements securely on hospital bed rails, operating tables, and gurneys, allowing tips to air-dry and preventing cross-contamination and droplet transmission. FDA-approved for 24-hour use, the product features a patented adjustable strap, bright orange visibility, and a raised grid base that prevents suction tips from resting in accumulated secretions. Suitable for use in ORs, ICUs, EDs, PACUs, LTACs, skilled nursing facilities, and rehabilitation settings. The device addresses the clinical and economic impact of HAIs—which affect 1 in 31 hospitalized patients at costs exceeding $25,000–$80,000 per infection—offering a cost-effective solution at only a few dollars per use. Manufactured from FDA-approved materials and fully recyclable.

ExThera Medical Corporation develops and commercializes the Seraph® 100 Microbind® Affinity Blood Filter, a single-use, extracorporeal blood filtration device designed to reduce pathogen levels in the bloodstream for patients with life-threatening bloodstream infections, sepsis, and related critical care conditions. The Seraph 100 employs proprietary microbead adsorption media with chemically-bonded modified heparin to selectively bind and remove pathogens—including bacteria, viruses, and endotoxins—from circulating blood while leaving the blood itself intact in the filter. The technology has been studied for COVID-19 treatment and is now advancing into clinical trials for broader infectious disease applications and oncology-related conditions through pipeline programs including ONCObind®. The company is advancing Phase I clinical trials (OSCAR I) for bloodstream infection management and exploring applications in pancreatic cancer treatment. ExThera's extracorporeal blood purification approach addresses a critical unmet need in intensive care settings where pathogenic load reduction can improve outcomes in sepsis, severe infections, and related hemodynamic compromise. The company maintains regulatory development pathways and publishes peer-reviewed clinical and preclinical data. Manufacturing and quality systems support single-use, sterile device production for hospital and critical care deployment.

ErgoMed, Inc. manufactures specialized medical tube securing and ventilator safety devices designed for use in anesthesia, respiratory therapy, ICU, emergency, trauma, surgery, EMS, rescue, and home health care settings. The company's primary product lines include Medical Tube Securing devices and the Ventilator Anti-Disconnect Device (Circuit Secure), which prevents unintended disconnection of ventilator tubing. Products are manufactured in the USA and are latex-free. The tube securing line utilizes state-of-the-art technology to ensure proper medical treatment with various tube apparatuses. Circuit Secure was designed by nurses to prioritize patient safety in critical care environments. ErgoMed distributes through a network of medical equipment distributors and positions itself on cost-effectiveness, comfort, simplicity, and safety for both healthcare providers and patients. The company operates from San Antonio, Texas.

Integrity Medical Products is a B2B supplier of medical equipment accessories, replacements, and consumables for healthcare facilities. The company specializes in patient monitoring cables and sensors (SpO2, ECG, invasive/non-invasive blood pressure) compatible with major monitor brands, available at 30–60% savings versus OEM pricing, with one-year warranties. Product portfolio includes monitor mounting arms and cable management systems (five-year warranty), nurse call accessories with pillow speakers (two-year warranty), medical carts and stands for monitors, ventilators, and suction pumps, and hospital furniture including overbed tables, bedside cabinets, fetal monitoring carts, bassinets, stools, and chairs with antimicrobial construction. Integrity also supplies suction and oxygen therapy products (analog and digital suction regulators, portable suction pumps, flowmeters, gas regulators, cylinder carts, high-pressure hoses) and offers patent-pending Integrated Flowmeter technology. Additional product lines include diagnostic systems (ophthalmoscopes/otoscopes with Welch Allyn compatibility), endoscopy/OR monitors and video accessories (wireless transmitters, fiber optic light cords, custom screen protectors), operating room table and stretcher pads (gel, foam, and self-adjusting air options for pressure ulcer prevention), and bed and stretcher accessories with custom fabrication available. The company targets hospitals, surgical centers, and critical care facilities, emphasizing affordability, compatibility with existing infrastructure, and practical solutions to institutional procurement challenges.

PICCGuard, LLC manufactures tamper-evident and tamper-resistant catheter access covers designed to protect patient safety and reduce iatrogenic complications associated with PICC (peripherally inserted central catheter) line tampering. The company's flagship product is a patented medical device that became the first tamper-resistant catheter access cover to receive FDA 510(k) clearance. The device employs tamper-evident technology to detect and resist unauthorized access to patient IV lines, addressing a critical patient safety gap in hospital and clinical settings. PICCGuard products are manufactured in the United States and have demonstrated significant cost savings in healthcare environments; a case study from James A. Haley VA Hospital documented average savings of $127,989.12 per patient stay through reduced adverse events and complications. The company is nurse-owned and operated by Katie Justus, R.N., bringing clinical expertise to device design. PICCGuard's technology directly supports infection prevention, patient sobriety protection, and reduction of opioid misuse in healthcare settings, addressing the broader opioid crisis context. Products are positioned for use in acute care, intensive care, and VA hospital environments where PICC line security and patient monitoring are critical.

SWIK Medical Solutions manufactures SWIK, a single-use, disposable medical device designed for automated oral secretion management in adults. The device provides continuous, hands-free management of oral secretions in the anterior oral cavity for up to 12 hours. Intended for patients with dysphagia (difficulty swallowing) who cannot independently manage secretions, SWIK addresses a significant clinical need in both intensive care and homecare settings. Clinical evidence from an NIH study demonstrates substantial reductions in ventilator-associated pneumonia (VAP), ICU length of stay, and mechanical ventilation duration. The device is positioned as the only hands-free, continuous oral suction solution available, offering comfort and dignity to patients while reducing aspiration risk and infection potential. Applications span ICU environments (particularly for mechanically ventilated patients) and homecare for individuals with swallowing disorders. The company emphasizes regulatory compliance and patient safety in its product development and positioning.

ClearFlow, Inc. manufactures specialized medical devices for cardiac surgery and cardiothoracic care. The company's primary product is PleuraFlow Active Chest Tube Clearance (ACT), a technology designed to prevent Retained Blood Syndrome and reduce postoperative complications in cardiac surgery patients. The PleuraFlow system actively clears blood and fluid from the thoracic cavity after surgery, demonstrating significant clinical benefits including 41% reduction in Retained Blood Syndrome, 17% reduction in postoperative atrial fibrillation, and 30% reduction in ICU length of stay when integrated into Enhanced Recovery After Surgery (ERAS) protocols. The company also offers ClearFix, a rigid sternal fixation system for stabilization and fixation of anterior chest wall fractures, including sternal fixation following sternotomy and sternal reconstructive procedures. ClearFlow's products are deployed in leading cardiac institutions and ICUs. The technology is supported by clinical evidence, including peer-reviewed publications demonstrating improved patient outcomes and resource utilization. The company serves cardiac surgeons, cardiothoracic surgical teams, and hospital ICU departments focused on reducing postoperative complications and improving recovery times in cardiac surgery populations.

Turn Medical is a medical device manufacturer specializing in automated prone positioning solutions for critically ill patients experiencing respiratory distress in intensive care settings. The company's flagship product, the Pronova-O2™ Automated Prone Therapy System, is an evidence-based device developed by critical care clinicians that simplifies and automates the prone positioning process, reducing caregiver burden and improving patient outcomes. The system offers three therapeutic modes: prone therapy, prone therapy with continuous lateral rotation, and supine rotational therapy. It integrates the InteliDerm™ Powered Skin Protection System to prevent pressure injuries. Turn Medical provides comprehensive support including clinical and technical training through Turn University, service contracts, rental and purchase options, and 24/7 customer support. The company has received recognition including a Vizient Breakthrough Technology Award and Innovative Technology Designation.

THE SURGICAL COMPANY INTERNATIONAL BV (TSC Life) is a global medical device manufacturer specializing in temperature management systems, fluid and blood warming devices, and single-use bronchoscopes for operating rooms, intensive care units, and emergency departments. The company's core product portfolio includes the Broncoflex® line of single-use bronchoscopes (including the XFlo variant with enhanced working channels for diagnostic and therapeutic procedures), Mistral-Air® forced-air warming systems, and Fluido® blood and fluid warming devices (Fluido Compact, Fluido AirGuard System, Fluido Irrigation). These solutions address patient safety through normothermia maintenance and cross-contamination prevention across surgical, critical care, emergency, and urological settings. TSC Life operates internationally from Amsterdam, The Netherlands, with US customer service and multiple distribution partners. The company emphasizes evidence-based design, infection control benefits through single-use construction, and workflow efficiency. Products serve pulmonologists, intensivists, anesthesiologists, and surgical teams in high-acuity environments including trauma, cardiac surgery, and complex oncology procedures. The company has received FDA clearance for pediatric use of the Fluido Compact system and maintains commitment to sustainable, accessible healthcare delivery with a target to reach 25 million patients annually.

VBM Medizintechnik GmbH is a family-owned German medical technology manufacturer founded in 1981, specializing in airway management devices, anesthesia and intensive care accessories, and electrically operated tourniquet systems. Based in Sulz am Neckar with approximately 200 employees, VBM develops and distributes innovative medical devices for hospitals, clinics, and emergency care settings. The company holds DIN EN ISO 13485 certification and operates globally with a U.S. sales office and partners in over 100 countries. Core product portfolios include laryngeal tubes (LT®evo, LTS-D), cuff pressure gauges, ventilation bags, intubation aids, breathing circuit accessories, tube fixation systems, and advanced tourniquet systems. VBM emphasizes quality, sustainability, and continuous innovation through strategic initiatives including ERP implementation and production partnerships.

CM Technologies Inc., operating as Consure Medical, manufactures specialized ICU care equipment focused on automated stool management and patient care optimization. Their primary product line addresses incontinence management in critical care settings, serving approximately 100 million annual incontinence patients and addressing a $10+ billion annual market. The company produces the Qoramatic Automated Stool Management Kit, featuring zero-pressure design (approximately 0 mmHg radial pressure) without inflation mechanisms to eliminate patient trauma, capable of reducing nursing intervention time by up to 174 minutes per day. They also offer the Qora-SMK, a manual intervention system providing fast medication and fluid delivery with stool sampling capability for critical care patients requiring additional care optionality. Products are designed to improve clinical workflows while reducing caregiver burden and patient discomfort. The company operates manufacturing and service capabilities with a US headquarters in Carrollton, Texas, and additional operations in New Delhi, India. Consure Medical markets to hospitals, ICUs, and critical care facilities seeking labor-reduction and patient safety solutions. The company maintains trademark registration and operates under FDA regulatory frameworks for medical device classification.

BPB MEDICA is an Italian-based medical device manufacturer specializing in minimally invasive surgical instruments and devices. The company operates fully integrated in-house production capabilities and serves multiple clinical specialties including spine surgery, orthopedic biologics, assisted reproduction technology, aesthetic procedures, and intensive care applications. Product lines encompass biopsy instrumentation, spinal surgical tools, orthobiologic delivery systems, and reproductive medicine devices. The manufacturer emphasizes precision engineering and innovation in minimally invasive techniques to improve patient outcomes and surgical efficiency. The company actively participates in major international medical conferences including MEDICA, EUROSPINE, Global Spine Congress, ESHRE, and NASS, indicating strong market presence in Europe and North America. BPB MEDICA demonstrates commitment to regulatory compliance and patient safety standards, including adherence to EU Medical Device Regulation requirements. The organization offers hands-on clinical training through initiatives such as the Verona Pain Academy to advance practitioner knowledge in regenerative techniques and osteoarthritis management.

Summit International Medical Technologies is a specialty medical device manufacturer focused on critical care, anesthesia, dialysis, and neonatal markets. The company develops, manufactures, and distributes clinically innovative disposable and durable medical products designed to enhance patient safety and clinician efficiency while providing cost-effective care solutions. Key product lines include: Covalon AquaGuard moisture barrier systems for IV sites, PICC lines, and wound dressings; Parasol Medical fall prevention systems (wired and wireless) and DrySmart incontinence management pads; Starboard Medical temperature management probes for patient monitoring; Summit Medical AngelTip Safety Fistula for dialysis access; SternaSafe Uni sternum support braces for post-sternotomy recovery and SternaBra for women; Parasol Medical Cultivate quality assurance products for aseptic procedures; and NDI disposable marking spheres for surgical navigation and tracking. The company also acquired the Critical Concepts Inc. neonatal distribution product line in 2020, expanding its NICU offerings. Summit operates primarily in the United States, serving hospitals, critical care units, dialysis centers, and surgical facilities. The company emphasizes clinician-trusted, easy-to-use solutions with measurable clinical outcomes such as reduced complications, faster patient recovery, and improved safety. Products are designed for both acute hospital settings and post-operative care environments.

CoapTech manufactures the PUMA-G System, the FDA-cleared ultrasound-guided percutaneous gastrostomy (PUG) solution for bedside feeding tube placement in critical care and acute care settings. The system enables physicians and advanced practice providers to perform gastrostomy procedures at the patient bedside using ultrasound visualization, eliminating the need for operating room scheduling, endoscopic reprocessing, or fluoroscopy exposure. Clinical evidence demonstrates significant hospital cost reductions (up to $34,778 per patient) and shortened ICU length of stay (5–10 days) compared to traditional PEG or PRG procedures. The PUMA-G System is deployed in ICUs, step-down units, floor units, interventional radiology suites, and long-term acute care hospitals. The system reduces procedural risks including organ perforation from blind sticks, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Key clinical applications include COVID-19 patient care (tandem tracheostomy–gastrostomy procedures) and integration into critical care teams to optimize patient throughput and procedural efficiency. CoapTech holds FDA 510(k) clearance and serves tertiary care centers, academic medical centers, community hospitals, and for-profit hospital systems across the United States.

Healthy Design Ltd. Co. manufactures innovative ICU solutions and clinical education systems focused on preventing delirium, improving early mobility, and enhancing patient and staff safety. Based in downtown Rutland, Vermont, the company designs, prototypes, engineers, and manufactures its products onsite. Founded by Dr. Marie Pavini (MD, FCCM, FCCP), an early expert in bedside medicine, restraint alternatives, sedation management, and post-intensive care syndrome (PICS), the company partners with prestigious academic medical centers and the National Institutes of Health on groundbreaking innovations. Primary product offerings include the Exersides® Refraint® device—a clinically proven restraint alternative that enables safe active range of motion while minimizing agitation and protecting against line and tube dislodgement for both adult and pediatric patients—and an immersive virtual reality simulation platform that trains care teams to recognize and manage delirium through experiential learning. The A+O x 3™ educational program provides evidence-based, multi-modality instruction (interactive scenarios, VR, in-person and remote learning) covering delirium prevention, ventilator weaning, sedation reduction, early mobility, restraint alternatives, nurse safety, and family engagement. The company also offers confidential policy audits and unit inspections to assess and strengthen patient-centered protocols. Products are designed for mechanically ventilated ICU populations, with specific attention to reducing iatrogenic complications, improving patient cognition and dignity, and decreasing healthcare burden from delirium and immobility-related morbidity. The organization has received recognition as Manufacturer of the Year for Vermont and New England (2024).

Anuncia Medical is a neurotherapeutic medical device company based in Scottsdale, Arizona, specializing in cerebrospinal fluid (CSF) management and neurocritical care solutions. The company develops noninvasive, clinically validated breakthrough devices designed to monitor, treat, and prevent shunt occlusions in patients with hydrocephalus. The ReFlow™ System Mini (ReFlow™ Mini Flusher) is their primary offering—an implantable device that allows patients to perform noninvasive CSF flushes by pressing the flusher located under the scalp, potentially restoring or maintaining shunt patency and reducing the need for repeat revision brain surgeries. The device received FDA Breakthrough Device Designation, indicating significant clinical potential. Anuncia addresses the substantial unmet need in hydrocephalus management, particularly affecting pediatric and geriatric populations. The company's team comprises medical device veterans collaborating with leading institutions and clinicians. Their technology targets both in-clinic and at-home management scenarios, reducing patient morbidity and healthcare costs associated with shunt revision procedures. The ReFlow™ Mini Flusher can be used with the ReFlow™ Ventricular Catheter, which features a relief membrane backup option providing alternate CSF flow pathways. Regulatory credentials include FDA Breakthrough Device Designation. The company actively engages with patient communities and professional associations to support hydrocephalus awareness and clinical education.

bioMérieux is a global in vitro diagnostics leader headquartered in France, with significant US operations. The company manufactures and distributes comprehensive diagnostic solutions for clinical microbiology, molecular pathology, blood culture detection, immunoassays, and rapid point-of-care testing. Core competencies span microbial identification and antimicrobial susceptibility testing (ID/AST), sepsis diagnosis and management, infectious disease detection (respiratory pathogens, gastrointestinal pathogens), and blood culture systems. Key product platforms include BIOFIRE® FILMARRAY® multiplex PCR systems, VITEK® MS PRIME mass spectrometry, BACT/ALERT® VIRTUO® blood culture automation, and VIDAS® immunoassay analyzers. The company also serves pharmaceutical and food safety markets with quality control and environmental monitoring solutions. bioMérieux addresses critical clinical challenges including antimicrobial resistance (AMR) stewardship, rapid sepsis identification, and respiratory infection diagnostics. Offerings span hospital laboratories, point-of-care settings, and industrial applications. The company emphasizes diagnostic-driven clinical decision support, workflow automation, and integrated laboratory information management. Manufacturing includes automated detection systems, rapid molecular platforms, and MALDI-TOF mass spectrometry instruments. US operations distribute test kits, reagents, and instruments through multiple channels including direct sales and the bioMérieux eShop. The company holds multiple regulatory clearances including FDA 510(k) approvals and CE marking for diagnostic instruments and test kits.

BrainSpace develops automated cerebrospinal fluid (CSF) management systems for acute care settings. The company's flagship product, the Intellidrop, automates external ventricular drainage (EVD) and lumbar drain management at the bedside, replacing labor-intensive manual monitoring with robotic precision and closed-loop automation. The Intellidrop features a wearable transducer that eliminates the need for manual leveling or zeroing, reducing nursing workload while improving patient experience and clinical outcomes. The system combines continuous sensing and gravity-based drainage principles trusted by neurosurgeons, enabling single-drop drainage control with personalized pressure or volume targets for each patient. The device generates high-frequency multimodal data that can be autonomously annotated in real-time, supporting research and AI training without manual data cleaning. BrainSpace's technology addresses CSF management for acute conditions including traumatic brain injury (TBI), hemorrhagic stroke, meningitis, post-neurosurgical care, and diagnostic evaluation for normal pressure hydrocephalus (NPH). The company targets ICU settings where improved automation is expected to support patient mobilization, reduce length of stay, alleviate nursing staffing challenges, and expand access to critical CSF management.

LeviSense Medical develops an advanced instrumented bed system designed to prevent and treat pressure injuries (pressure ulcers/bed sores) through high-resolution sensing and automated surface control. The LeviSense Pro-Daptive™ SensorCell™ Flotation Surface continuously scans patient form, position, and movement multiple times per second, automatically adjusting the support surface to redistribute pressure and protect vulnerable areas without requiring caregiver intervention. The system features 16 programmable sections for patient-specific customization, Dynamic Offloading™ for automated pressure relief, and Heel Flotation™ for targeted protection. Key benefits include reduced nursing labor demands, decreased repositioning-related injury risk to patients and caregivers, and enhanced patient comfort through advanced envelopment technology. Compatible with standard hospital and home bed frames, the system integrates remote monitoring capabilities and is designed for seamless deployment across ICU through home-care settings, supporting institutional and home-based care delivery models.

Patient Safety Systems Inc manufactures fall prevention and therapeutic support systems for healthcare facilities. The company specializes in safety covers and pressure relief mattresses designed to reduce patient fall risk and provide comfort during therapy and recovery. Their product portfolio includes the Safe & Secure Safety Cover line (5 different styles) and Flotation Air mattress systems with optional heel-off technology. All Flotation Air and Flotation Air Plus mattresses are supplied with integrated Safe & Secure Safety Covers. These systems employ pneumatic flotation technology with whisper-quiet pumps to support pressure management and patient positioning. The company serves acute care hospitals, rehabilitation centers, and long-term care facilities, positioning itself as a specialty support and fall prevention provider. Products are clinically proven and designed for diverse patient needs ranging from standard to complex care requirements.

CardioRenal Systems develops the RenalPro (RenalGuard outside the US) autonomously-controlled fluid management and therapeutic system designed to prevent acute kidney injury (AKI) across multiple clinical settings. RenalPro is an FDA-designated breakthrough device that responds to minute fluctuations in urine output while automatically adjusting IV fluid administration in 1 mL increments to maintain hemodynamic stability and prevent over- or under-hydration. The company's primary focus is cardiac surgery-associated AKI (CSA-AKI), where approximately 30% of patients suffer kidney injury post-operatively. In a randomized 220-patient UK study, RenalPro demonstrated a 52% reduction in AKI compared to standard care with no reported adverse events. The system also addresses contrast-associated AKI (CA-AKI) in catheterization lab procedures and shows potential for ICU-related AKI prevention in septic and critically ill patients. RenalPro integrates into existing clinical workflows and represents an alternative to traditional KDIGO bundle protocols, which demonstrate limited efficacy. The company holds ISO 13485 certification and FDA breakthrough device designation, positioning it as a specialized solution for kidney injury prevention in surgical and interventional cardiology settings.

Totex Manufacturing Inc. is a US-based designer and manufacturer of custom battery packs and charging systems serving medical, industrial, aerospace, and consumer markets since 1985 (35+ years of experience). The company provides comprehensive solutions from initial design through manufacturing, testing, and global logistics. In the medical sector, Totex supplies rechargeable batteries and chargers for portable diagnostic devices (ultrasound machines, blood pressure monitors, insulin pumps, portable monitors), portable medical equipment, and ICU/emergency devices requiring reliable power in demanding environments. The company manufactures to rigorous medical standards and maintains FDA registration. Core manufacturing capabilities include circuit design and PCB layout, fuel gauge and MCU firmware programming, in-house SMT assembly (7 fully automatic lines), plastic injection molding (27 machines), ultrasonic and spot welding, and automated cell sorting. Quality systems include ISO 9001, ISO 13485, and ISO 14001 certifications, with in-house UL2054 testing, Six Sigma training (1 master black belt, 2 black belts, 30+ green belts), and DPPMs typically <500 per year. Environmental testing capabilities in-house include temperature cycling, thermal shock, humidity, IP68 dust/water intrusion, vibration, drop, shock, and nail penetration testing. The company operates two manufacturing facilities (Torrance, California: 55,000 sq. ft.; Huizhou, China: 120,000 sq. ft.) with vertical integration enabling cost-effective and consistent production. Expertise spans all major cell chemistries: Li-Ion, LiFePO4, NiMH, Li-SOCl2. Logistics support includes ~98% on-time delivery, Kanban/VMI/consignment programs, and specialized handling of lithium-ion battery shipping regulations. Designs include autoclave and intrinsically safe ratings for medical applications.

Recovery Force Health develops innovative wearable medical devices and digital health solutions focused on early mobilization, deep vein thrombosis (DVT) prevention, and hospital-acquired pressure injury (HAPI) prevention. Founded in 2018 and based in Fishers, Indiana, the company specializes in data-driven therapeutic compression and patient positioning technologies for acute care hospital and home settings. Core product portfolio includes MAC™ (Movement and Compression), a wearable therapeutic compression device that measures and displays real-time patient compliance and mobility data; ELEVATE™, a patient positioner designed to offload the sacrum while enhancing comfort and compliance; and HeelP.O.D.™, a foot offloading device with immersion and envelopment technology for visual assurance of pressure relief. All devices integrate clinical data capture to support workflow optimization and patient outcomes tracking. The company has established clinical partnerships with Mayo Clinic since 2018 to develop wearable medical-tech garments. Recovery Force Health emphasizes evidence-based design: studies demonstrate that early progressive mobilization—including periodic positioning changes, transfers, and ambulation—is associated with improved functional recovery, reduced hospital costs, and shorter length of stay. The company has received industry recognition including Stevie Awards, Edison Awards (Bronze), TechPoint MIRA recognition, and HealthTech Top 100 designation. Recent press releases indicate significant revenue growth (threefold increase through 2025) and expanded market adoption across hospital systems. Products address clinical needs in acute care ICU, post-operative, and extended care settings where DVT and pressure injury prevention are critical quality and cost drivers. Recovery Force Health targets hospital systems, health networks, and home care providers seeking to improve patient mobility outcomes and reduce preventable complications.

AccuVein is a medical device manufacturer specializing in near-infrared (NIR) vein visualization technology for vascular access procedures. The company develops handheld vein finder devices that enable healthcare professionals to visualize peripheral veins, valves, and bifurcations not visible to the naked eye, improving peripheral IV catheter placement success rates and reducing procedure time and complications. AccuVein's primary products serve acute care settings (emergency departments, ICUs, general wards), non-acute care environments (outpatient clinics, home care), and aesthetic/cosmetic medicine practices. Clinical evidence supports the technology with 92% first-attempt success rates for IV placement, 78% reduction in procedure time, 45% decrease in escalation calls, and 39% reduction in patient pain. The company manufactures multiple generations of vein visualization devices, including the AV500, AV600 (fourth-generation model recently launched), and associated accessories such as the HF580 Powered Stand for hands-free mobile applications. AccuVein's devices are recommended by leading professional societies for pre-insertion vascular assessment and are positioned to improve clinical outcomes, operational efficiency, staff well-being, and healthcare equity by enabling successful venous access across diverse patient populations.

Pronia Medical Systems develops GlucoCare, an FDA-cleared insulin dosing calculator software designed for critical care settings. GlucoCare is a web-based medical device that runs on standard browsers within hospital intranets or via cloud deployment, requiring minimal IT infrastructure for installation. The system implements the Yale Protocol—a customized, patient-response-based insulin dosing algorithm that accounts for current blood glucose, prior glucose trends, measurement intervals, and current insulin rate to calculate real-time insulin resistance and recommend safe dose adjustments. Clinical evidence demonstrates GlucoCare achieves hypoglycemia rates below 0.2% for readings <70 mg/dL while maintaining target glucose ranges. The platform supports multiple protocol variants (GlucoCare-140, GlucoCare-160) with configurable target ranges (100–160 mg/dL) and allows clinician overrides with quality assurance documentation. Built-in analytics provide unit-level and individual-user tracking for glucose control compliance and protocol adherence, enabling continuous quality improvement. GlucoCare integrates with hospital EMR systems and has been validated in peer-reviewed literature (Diabetes, Technology and Therapeutics). The company partners with EHR platforms including Cerner-based systems. Intended users are primarily nurses and critical care teams in hospital ICU settings managing patients requiring insulin infusions.

SeaStar Medical is a clinical-stage immunotherapy company developing the Selective Cytopheretic Device (SCD), a patented therapeutic platform designed to treat destructive hyperinflammatory responses in critically ill patients. The SCD selectively targets and neutralizes highly activated neutrophils and monocytes responsible for cytokine storms—uncontrolled inflammatory cascades triggered by trauma, infection, or surgery that can lead to multiorgan failure and death in ICU settings. The device integrates seamlessly into existing hemodialysis delivery systems, offering a disease-modifying approach to restore immune balance without requiring standalone infrastructure. SeaStar's technology addresses a significant clinical gap: there are currently no FDA-approved therapeutic options specifically designed to calm hyperinflammation in this patient population. The company's clinical evidence supports that SCD therapy may reduce ICU length of stay, decrease dialysis dependency, and improve survival outcomes. The device is positioned for use in critical care and intensive care units treating sepsis, post-surgical complications, and trauma-induced inflammatory responses. SeaStar Medical is headquartered in Denver, Colorado, and is focused on advancing the critical-care treatment paradigm through robust scientific validation and regulatory pathways.

Surgicure Technologies, Inc. is a medical device company specializing in airway management solutions for civilian and military healthcare applications. The company's flagship product, the HORSESHOE™, is a novel endotracheal (ET) tube securement device designed to address critical safety and comfort challenges in critical care settings. The HORSESHOE™ features a patented off-the-face horseshoe-shaped design with a robust locking mechanism, integrated molar props, and an adjustable track that accommodates ET tubes sized 6.5 to 10 mm. The device is engineered to eliminate medical device-related pressure injuries (MDRPIs) on the face by operating independent of facial skin or lip contact, eliminating the need for adhesives, tape, wires, or additional dressings that commonly cause pressure points and irritation. The HORSESHOE™ facilitates rapid ET tube repositioning via its smooth locking track, enabling assessment and cleaning of facial skin while maintaining airway security. Clinical applications include support for chemotherapy patients with TENS devices, patients with facial trauma, pressure injuries, burns, beards, and emaciated patients. The device supports essential VAP (ventilator-associated pneumonia) prevention practices per 2022 ICHE Guidelines and complies with International NPIAP MDRPI Prevention Guidelines. Surgicure is backed by prominent venture investors including Techstars, BakerBridge Capital, NSF Innovation Corps, and others. The company operates from Cambridge, Massachusetts, and is committed to reducing unplanned extubations, enhancing patient comfort, and standardizing ET tube stabilization practices across critical care environments.

Guldmann North America is a specialized provider of safe patient handling and mobility solutions for healthcare environments. Founded in 1980 and headquartered in Tampa, Florida with offices in Medford, Massachusetts, the company delivers ceiling hoists, mobile lifters, patient slings, and comprehensive accessories designed for emergency care, intensive care, operating rooms, rehabilitation, and long-term care settings. Guldmann emphasizes early mobilization protocols that improve patient recovery outcomes while reducing caregiver injury risk through ergonomic design. Beyond equipment, the company offers integrated services including project consultancy, installation, training in safe patient handling techniques, and on-site support. With a global distributor network spanning Iceland to Australia and substantial service capabilities, Guldmann positions itself as one of the world's largest providers of ceiling hoist system installation and maintenance, serving hospitals, care facilities, and home care environments.

Integrated Medical Systems, Inc. is a medical equipment distributor and service provider specializing in home infusion therapy, respiratory equipment, and enteral delivery devices. The company operates as a multi-service medical supplier offering rental, lease, and sales options for infusion pumps, IV poles, transfer devices, and wound care consumables under the IMed brand. Core business segments include equipment rentals tailored to treatment protocols and budget constraints; ISO-certified biomedical servicing and repair as a cost-effective alternative to in-house maintenance; asset management software (iQuest) providing real-time tracking and location monitoring of medical equipment; and cleanroom product consulting with USP 797 and USP 800-compliant supplies for controlled pharmacy environments. The company serves home infusion providers, healthcare facilities, and ambulatory care settings. Featured products include IMed EZ-FLOW infusion pumps (100mL and 270mL configurations at variable flow rates), IV poles (steel and disposable models), mini transfer pins, and elastic net tubular bandages in multiple sizes. The company maintains distribution operations and appears to serve national markets based on closure announcements for multiple locations. Services emphasize cost-effective equipment upkeep, regulatory compliance for compounded sterile preparations, and integrated asset visibility for hospital and infusion clinic operations.

Codonics, Inc. is a Cleveland-based medical technology innovator specializing in patient safety and medication management solutions. Founded in 1982, the company has deployed over 60,000 installations across more than 110 countries. The Safe Label System (SLS)—Codonics' flagship product—enhances medication safety through real-time barcode scanning and automated labeling at the point of care, reducing administration errors and ensuring TJC and ISMP compliance. SLS integrates seamlessly with anesthesia drug carts and pharmacy workflows across operating rooms, intensive care units, patient floors, and pharmacy departments. Additional offerings include the SLS-Wave (hands-free scanning), Safe Waste System (controlled substance tracking), WasteLog (waste verification), and SLS Administration Tool (formulary management). Recognized as a Top 100 Healthcare Technology Company of 2024 and awarded Medication Safety Technology Company of the Year 2025, Codonics delivers solutions that streamline clinical workflows, improve charge capture, ensure 340B compliance, and prevent medication errors in perioperative and procedural settings.

D • R Burton Healthcare manufactures respiratory care and anesthesia devices founded by healthcare clinicians specializing in positive expiratory pressure (PEP) therapy and airway management. The company produces a portfolio of OPEP (Oscillating Positive Expiratory Pressure) and PAP (Positive Airway Pressure) devices designed to improve patient outcomes in respiratory therapy, reduce hospital readmissions, and decrease ICU length of stay. Product lines include vPEP® (oscillating OPEP therapy), iPEP® (volume-based incentive OPEP device with visual feedback), PocketPEP® (portable OPEP therapy), OxyPAP® and OxyJet® (PAP therapy systems), OxyBreath™ and OxyTrainer™ Advantage (respiratory muscle training devices), and J-Wand airway management intubation systems. The company emphasizes clinician-guided design and value-driven innovation. Based in Farmville, NC, D • R Burton Healthcare serves acute care hospitals, rehabilitation facilities, and respiratory therapy clinics. Devices support post-operative recovery, prevention of respiratory complications, and management of chronic respiratory conditions. The iPEP® is specifically highlighted for reducing rehospitalizations through volume-based feedback that enables clinicians to verify adequate patient air intake during therapy.

NeVap Inc manufactures airway management devices focused on infection prevention and critical care outcomes. The company's flagship product is the Aspire Subglottic Endotracheal Tube (ASSET), a subglottic suction breathing tube engineered with a tissue spacer and multiple drainage ports to prevent tissue blockage during suctioning. The ASSET is designed to reduce ventilator-associated pneumonia (VAP), post-operative pneumonia, and aspiration pneumonia incidence by enabling effective subglottic drainage in ICU, operating room, and emergency department settings. Clinical evidence demonstrates that subglottic drainage reduces mechanical ventilation duration, pneumonia incidence, antibiotic consumption, and mortality in long-term ventilated patients. The device is supported by recommendations from the CDC, AHRQ, ATS, SHEA, APIC, IDSA, and AACN. NeVap's leadership includes medical device executives and FDA compliance experts, with an advisory board composed of life sciences professionals. The company is positioned to serve hospitals and healthcare systems across the Bay Area and beyond, addressing a significant clinical need in airway management and infection prevention protocols.

Ondal Medical Systems GmbH is a global manufacturer of suspension arm systems and medical pendant carrier systems for hospitals, operating rooms, intensive care units, and diagnostic imaging areas. Founded in 1945 and headquartered in Hünfeld, Germany, the company operates as a B2B supplier specializing in customized ODM/OEM solutions for hospital suppliers and medical technology companies. With over 3 million suspension arms installed in approximately 70% of hospitals worldwide, Ondal designs and manufactures medical device suspension systems, surgical light positioning systems, medical display mounting solutions, and ceiling-mounted supply units. The company holds CE and UL certifications and complies with ISO 13485 medical device standards. Ondal provides comprehensive services including installation, maintenance, repairs, technical support, and product training through a dedicated Technical Service Department. Their solutions optimize workflow efficiency and ergonomics across operating rooms, radiology departments, examination rooms, and ICU environments.

IDMED develops and markets innovative medical devices for anesthesia and intensive care monitoring. The company specializes in automated pupillometry and neuromuscular transmission (NMT) monitoring solutions used globally in operating rooms and ICU settings. The NeuroLight® pupillometer provides accurate, automated measurement of pupil size and reactivity for neurological assessment and prognostication in intensive care environments. The ToFscan® is a quantitative neuromuscular blockade monitor utilizing three-dimensional sensors with a wide sensor range and requires no pre-use calibration. Both products are designed to enhance clinical decision-making and patient safety in perioperative and critical care settings. IDMED's focus on neurological and neuromuscular monitoring positions the company within the specialty diagnostic and patient monitoring equipment segment, serving anesthesiology, critical care, and neurology departments.

DRW Medical manufactures specialized respiratory and monitoring equipment for neonatal and pediatric intensive care settings. The company's primary product lines focus on non-invasive ventilation support and patient safety monitoring for infants. NAPA Monitoring systems (LP-15 and LP-35 monitors) are designed to provide real-time pressure and waveform data during Bubble CPAP (continuous positive airway pressure) and Nasal High Flow (NHF) therapy, preventing complications such as pneumothorax and desaturation events caused by disconnects or inadequate pressure delivery. The NAPA LP-35, their newest offering, features enhanced capabilities including real-time waveforms and touchscreen operation, paired with their flow-pro Dual Lumen Cannula to monitor dynamic resultant pressures and optimize safe flow rates in high-flow nasal cannula therapy. The Exsalta Smart Suction system represents innovation in endotracheal tube clearance, delivering suction efficacy comparable to wall suction while minimizing negative lung pressure—a critical consideration in neonatal care. DRW Medical serves a broad network of U.S. hospitals and health systems, including major academic medical centers, children's hospitals, and regional hospital networks across all 50 states. Their customer base includes institutions such as Duke University Hospital, Nationwide Children's Hospital, Robert Wood Johnson, and numerous Advent Health and Wellstar facilities. The company exhibits strong market penetration in neonatal and pediatric critical care, positioning products for clinicians managing complex airway and respiratory management in vulnerable patient populations.

Narang Medical Limited is a leading India-based manufacturer and supplier of medical equipment, surgical instruments, hospital furniture, and orthopedic implants. Established in the early 1950s and incorporated in 1989, the company has achieved sustained growth with an average annual export growth rate of 40%. Operating across 80+ countries with international subsidiaries and distribution networks, Narang Medical serves hospitals, clinics, and healthcare systems globally. The company manufactures over 1,000 medical products across 25+ categories, including operating room equipment, diagnostic instruments, ICU systems, laboratory devices, anesthesia equipment, sterilization solutions, dental instruments, physiotherapy equipment, and neonatal care systems. ISO 9001:2015, ISO 13485:2016, and CE certified, Narang Medical is recognized as a Star Export House by the Government of India. Known for competitive pricing without compromising quality, prompt delivery, and customer-friendly policies, the company supplies products that are frequently distributed under private labels by European importers.

MetroMed Inc. is a U.S. specialty medical device and supplies distributor founded in 1989, headquartered in Rochester, NY. The company specializes in neonatal, pediatric, labor & delivery, anesthesiology, respiratory therapy, and infertility (IVF) medical devices and supplies. MetroMed operates as both a direct supplier to hospitals, surgery centers, and clinics across the Northeast and Mid-Atlantic regions (NY, NJ, PA, DE, MA, ME, CT, RI, NH, VT, MD, DC, VA, and W.VA), and as a regional/national distribution partner for manufacturers. The company is a contracted supplier with health systems and children's hospitals throughout the Northeast and Mid-Atlantic. MetroMed's service model emphasizes clinical education, in-person product demonstrations, staff training, and responsive customer support. Inventory management, reliable two-day regional delivery, expedited shipping, and backorder support are core capabilities. The company serves acute care settings, clinics, and IVF facilities with clinically validated products designed to improve patient outcomes, enhance quality, and reduce costs.

Intersurgical is a global designer, manufacturer, and supplier of high-quality medical devices specializing in respiratory care and airway management. The company provides flexible patient solutions across four primary product lines: Airway Management (airway devices, accessories, patient connections, breathing filters, HMEs, HMEFs, and atomisation devices); Anaesthesia (face masks, breathing and resuscitation systems, carbon dioxide absorbents, and head positioning devices); Critical Care (patient interfaces, breathing systems, CPAP devices, oral care, and closed suction systems for ventilatory support); and Oxygen and Aerosol Therapy (fixed and variable concentration oxygen therapy, aerosol therapy, humidification, and nebulisation products). The company serves emergency care, hospital, and home care settings. Intersurgical maintains comprehensive product documentation systems, educational resources, and clinical evidence materials. The organization operates through a global sales network with multiple regional offices and distributors. The company demonstrates commitment to quality and environmental management standards and publishes annual sustainability reports. Intersurgical offers neonatal and pediatric product lines, sterile ranges, and home care ranges supported by detailed product catalogues and instructional documentation.

Medovate Limited is a UK-based medical device development and commercialization company specializing in bringing novel clinical innovations to market through structured partnerships with NHS clinicians and healthcare providers. The company operates across the full medical device development pipeline—from initial concept evaluation and clinical development through regulatory approval and global market launch. Medovate's current product portfolio includes Safira® (regional anesthesia injection safety system with automatic pressure limiting to reduce nerve injury risk), Glucosave® (critical care blood sampling safety device to prevent inappropriate insulin administration), Humidicare® (heat and moisture exchanger with visual alerts for mechanical ventilation circuits), LUMEVAC™ (endoscopic surgical device for management of life-threatening gastrointestinal tract infections), and CamPROBE (transperineal prostate biopsy facilitation device). The company leverages deep relationships with NHS institutions to validate medical needs, conduct clinical trials, and accelerate adoption of approved technologies. Medovate focuses on patient safety innovations and clinician-centered design, with demonstrated capability in securing regulatory clearance and driving market entry across multiple therapeutic domains including anesthesia, critical care, endoscopic surgery, and urology. The firm's model emphasizes unmet clinical needs resolution and cost-effective solutions for healthcare systems globally.

AirICU Inc. manufactures and distributes aerosol drug delivery systems for acute care and intensive care unit (ICU) environments. The company's primary product line focuses on nebulization solutions for critical care applications. AirICU Max+ is a medical mesh nebulizer designed for hospital and acute care settings, delivering aerosolized medications to critically ill patients. The company positions itself as a provider of full-scenario nebulization support for critical care facilities. Products are designed for use in ventilated and non-ventilated patient populations in ICU environments. The company serves hospital acute care departments and critical care units. No specific FDA clearance, ISO, or regulatory certifications are mentioned on the fetched website content, though such approvals would be expected for ICU medical devices distributed in the US market.

Mercury Medical is a specialty healthcare manufacturer and distributor headquartered in Clearwater, Florida, with over 60 years of operational history since 1963. The company designs, manufactures, and distributes innovative medical devices for critical care environments, with primary focus on emergency, anesthesia, respiratory, and neonatal markets. Mercury Medical's product portfolio includes airway management devices, resuscitators, CPAP systems, T-piece infant resuscitators, bag-valve-mask devices, video laryngoscopes, hemostatic gauze, and CO2 absorbent solutions. The organization provides comprehensive customer support including training seminars, virtual product demonstrations, and equipment maintenance services to hospital systems and healthcare facilities. Mercury Medical also operates as an OEM partner and maintains distribution agreements with regional healthcare networks and procurement groups such as HealthTrust Performance Group.

Prenosis Inc. is a Chicago-based precision medicine and artificial intelligence company founded in 2014, specializing in AI-powered diagnostics for acute care settings. The company's flagship product, the Sepsis ImmunoScore™, is the first FDA De Novo-authorized AI diagnostic tool for sepsis diagnosis and prediction of adverse outcomes. It integrates seamlessly into hospital electronic medical records and provides real-time clinical decision support by combining biomarker analysis with clinical data. The proprietary Immunix® precision medicine platform captures extensive biomarker and clinical data from acute care patients, enabling the development and real-time deployment of precision medicine tools. This platform has built the world's largest biobank linked to clinical infection data in acute care, encompassing over 138,000 longitudinal specimens and 35,000 patients across 11+ hospitals. Prenosis partners with Roche Diagnostics for distribution through the navify® Algorithm Suite. The company empowers clinicians to move beyond symptom-based diagnoses toward biology-based treatment decisions, improving patient outcomes and reducing hospital costs while supporting quality metrics.

Kreg Therapeutics is a specialty hospital bed provider focused on therapeutic solutions for complex ICU and acute care patients. The company designs and manufactures specialty beds in the USA, including the Catalyst® Critical Recovery Bed featuring proprietary In-Bed Verticalization™ technology, which enables clinicians to safely position high-acuity patients upright while bedridden. This therapeutic approach accelerates mobilization and recovery for complex patients with conditions including organ transplant, burn injuries, ECMO support, and ventilator dependence. Kreg also offers bariatric beds (E-Z Wider®), acute care low beds, pressure injury management mattresses, and ancillary patient handling accessories. The company operates a high-touch service model with owned regional service centers, providing on-site product delivery, setup, staff training, and 24/7 support. Kreg serves over 350,000 patients annually across US hospitals, with particular adoption among trauma centers and critical care facilities seeking to improve patient outcomes, reduce length of stay, and enhance clinician safety during complex patient handling.

Transonic Systems Inc. is a medical device manufacturer specializing in ultrasonic Transit-Time blood flow measurement technologies. Founded in 1983 and headquartered in Ithaca, New York, the company provides precision measurement solutions for surgical, clinical, research, and OEM applications. Transonic's product portfolio includes intraoperative blood flow meters for cardiothoracic, cerebrovascular, transplant, and microvascular surgery; hemodialysis flow monitors for vascular access assessment; mechanical circulatory support flow measurement systems for ECMO and cardiopulmonary bypass; tubing flowsensors for biomedical research and device manufacturing; and comprehensive life science research instrumentation for blood flow, pressure, and cardiac output measurement. The company also offers Transonic-Inside™, a customizable OEM integration program enabling medical device developers to embed advanced flow measurement capabilities into their platforms. With global operations across the US, Europe, Asia, Japan, and Taiwan, Transonic serves hospitals, research institutions, and medical device manufacturers seeking gold-standard accuracy and validation-backed measurement solutions.

Sarnova HC, LLC is a holding company for a portfolio of healthcare distribution and services companies serving the emergency medical services (EMS), acute care, and hospital sectors. The company operates four primary brands: Bound Tree Medical, a national distributor of prehospital EMS supplies, equipment, and pharmaceuticals for first responders and paramedics; Tri-anim Health Services, providing respiratory, anesthesia, and critical care products to hospitals and health systems; Cardio Partners, specializing in automated external defibrillators (AED), sales, repair services, program management, and CPR training for sudden cardiac arrest prevention; and Digitech, a cloud-based billing and technology platform serving the EMS transport industry. Collectively, Sarnova and its subsidiaries distribute more than 100,000 health and safety products to thousands of providers across emergency care, hospitals, advanced patient-care facilities, schools, universities, businesses, and federal government agencies. The company has nearly 50 years of operational history and serves approximately 32,000 customers nationwide. Sarnova is owned by Patricia Industries, part of Investor AB. The company emphasizes clinical expertise, in-service training, and comprehensive support across the continuum of care.

Daxor Corporation is a medical device company founded in 1970 and headquartered in Oak Ridge, Tennessee, specializing in blood volume measurement technology. The company's flagship product, the BVA-100 Blood Volume Analyzer, is an FDA-cleared diagnostic system that uses indicator dilution technique with I-131 Human Serum Albumin to provide precise quantification of total blood volume, plasma volume, and red cell mass in adult patients. The BVA-100 calculates normalized hematocrit and albumin transudation rate, enabling clinicians to detect hidden fluid imbalances that indirect measures miss. Daxor also supplies Volumex diagnostic kits, the radiopharmaceutical component required for blood volume analysis procedures. The technology is designed for hospital laboratory settings and clinical departments requiring critical fluid management decisions, including heart failure, critical care, sepsis, ARDS, syncope, and surgical blood loss assessment. The system is reimbursed by both public and private payers for inpatient and outpatient use, with demonstrated clinical outcomes in reducing mortality and hospital readmissions.

OralKleen is a Fall 2019 Arizona Innovation Challenge Award-winning medical device company specializing in comprehensive oral care solutions for hospitalized and ventilated patients. The company addresses the critical gap in oral hygiene delivery for incapacitated patients in ICU settings, with a primary focus on reducing Ventilator-Acquired Pneumonia (VAP)—a hospital-acquired infection affecting up to 50% of mechanically ventilated patients and resulting in 10–50% mortality among those infected. OralKleen's integrated system combines specialized oral care products with an innovative electric toothbrush featuring LED illumination and suctioning capability, enabling safe and efficient plaque removal while providing clear visibility for caregivers. Clinical studies demonstrate significant improvement across key oral health metrics (tongue, teeth, mucosa, and gingiva) and dramatic VAP rate reductions when comprehensive OralKleen care replaces standard protocols. The system delivers superior clinical outcomes at price parity with traditional, less effective methods, making it a cost-effective solution for hospital infection prevention programs.

N8 Medical LLC is a clinical-stage medical device company specializing in antimicrobial coating technology based on ceragenins—a novel class of active compounds that mimic innate immune system antimicrobial peptides. The company's lead product, CeraShield, is an antimicrobial coating applied to indwelling medical devices and implants to prevent hospital-acquired infections (HAIs) and biofilm formation. The flagship device is the CeraShield Endotracheal Tube (ETT), designed to prevent Ventilator-Associated Pneumonia (VAP), the most common and costly HAI in ICU settings with estimated global treatment costs exceeding $10 billion annually. The FDA has designated CeraShield ETT as a "Breakthrough Device" and it is cleared for routine clinical use in Canada, Colombia, Brazil, and the UAE, with FDA approval anticipated. N8 Medical's pipeline includes additional CeraShield-coated devices: an antimicrobial absorbable pacemaker envelope for prevention of cardiac implantable electronic device (CIED) infections, and coated pedicle screws for orthopedic implant-associated infection prevention. The company is also developing CeraShield-coated hemodialysis catheters. N8 Medical operates as part of N8 Biosciences holding company and maintains a pharmaceutical subsidiary, Kinnear Pharmaceuticals, advancing therapeutic drug development using ceragenins for cystic fibrosis and other conditions. The company has received multiple NIH SBIR grants and maintains partnerships with government agencies including USAMRIID for biodefense applications.

Kol Bio-Medical Instruments, Inc. is a medical device sales and distribution company specializing in direct sales representation, supply chain management, and go-to-market strategies for medical device manufacturers. The company operates as a strategic partner to device makers, providing clinically-oriented sales teams, market access, product revitalization services, and end-to-end warehousing and distribution capabilities. The company serves multiple hospital departments and procedural areas including interventional cardiology and radiology labs, operating rooms, critical care units, cardiac surgery programs, trauma centers, and neonatal intensive care units (NICU). Their expertise spans diagnostic and therapeutic devices used in acute care settings, life-support technologies, and specialized surgical equipment. Kol Bio-Medical combines direct sales representation with supply chain logistics, offering complete go-to-market planning, clinical education, inventory management, order fulfillment, and product tracking. The company employs representatives with clinical expertise who can educate healthcare providers on device applications and customer-level technical concepts. Core service offerings include growth strategy development, product line revitalization for mature devices, and comprehensive distribution from their Sterling, Virginia warehouse facility. The company does not manufacture devices but rather functions as a trusted distributor and sales partner for third-party medical device manufacturers seeking to expand market presence and revenue in hospital and acute care settings.

Ondine Biomedical Inc. is a Canadian life sciences company specializing in photodisinfection (antimicrobial photodynamic therapy) technologies for infection prevention and treatment. The company's patented platform uses non-thermal laser light activation with photosensitive agents to destroy bacteria, viruses, yeasts, fungi, and associated virulence factors within minutes—without generating antimicrobial resistance. The lead product, Steriwave, is a rapid nasal decolonization therapy that eliminates broad-spectrum pathogens including methicillin-resistant Staphylococcus aureus (MRSA), Candida auris, and SARS-CoV-2 from the nasal cavity, significantly reducing healthcare-associated infections (HAIs) and surgical site infections (SSIs). Clinical evidence from major Canadian hospitals demonstrates up to 84% reduction in postoperative infection rates and 39.5% pneumonia reduction in ICU settings. Photodisinfection offers advantages over traditional antibiotics including immediate pathogen destruction, potent anti-inflammatory effects, and safety for patient outcomes. The company maintains a pipeline of investigational products addressing chronic rhinosinusitis, burn and wound decolonization, endotracheal tube disinfection to prevent ventilator-associated pneumonia, and topical antiviral therapies for upper respiratory tract infections. Ondine's technology platform is designed for straightforward clinical adoption with minimal workflow disruption and no complex compliance barriers. Note: Products are not currently for sale in the United States. The company operates as a specialized biomedical device and therapeutic solutions provider focused on addressing antimicrobial resistance through innovative light-activated infection control mechanisms.

CenterPoint Systems LLC manufactures innovative medical devices and products serving the cardiovascular, respiratory, gastrointestinal, and critical care markets. Based in West Valley City, Utah, the company develops specialized equipment for acute and critical care settings, with a focus on supporting clinical outcomes in high-acuity patient populations. CenterPoint serves healthcare facilities through direct sales and customer support channels.

Vitaltec Corporation is a medical device manufacturer specializing in airway management and respiratory care products. The company develops and supplies closed suction systems, tracheostomy tubes (including subglottic suction variants), and oral care systems designed to prevent ventilator-associated pneumonia (VAP) and enhance infection control in intubated patients. Vitaltec's product portfolio includes proprietary brands: Vita-Cath, Rota-Trach, and Venti-Trach, each developed with patent-protected innovative designs and clinical input. The company emphasizes patient safety and comfort in all product design. Vitaltec maintains ISO 13485 certification, demonstrating compliance with international quality management standards for medical devices. The organization provides comprehensive clinical education resources on VAP prevention and respiratory care best practices to healthcare professionals. Products are marketed for ICU and critical care environments where infection prevention and patient monitoring are paramount. The company operates a global distribution and partnership model, positioning itself as a B2B supplier to hospitals, healthcare systems, and medical equipment distributors worldwide.

Med Way Inc. (MedWay Group) is a global provider of innovative wound care products and clinical best practices, founded in 2008 and headquartered in the Greater Atlanta area. The company employs approximately 74 staff members, including clinicians and engineers. MedWay specializes in advanced wound care dressings—including collagens, alginates, hydrocolloids, foams, silicone foams, and antimicrobial dressings—as well as nano silver wound care solutions and alternating pressure low air loss mattress systems. These products are designed to accelerate wound healing, reduce supply costs, simplify application protocols, and improve caregiver efficiency. MedWay serves extended care facilities, home care providers, hospitals, and healthcare systems worldwide, offering customized support services and educational tools developed collaboratively with healthcare professionals to optimize supply chain management and clinical outcomes.

Serim Research Corporation is a manufacturer of specialty diagnostic test strips founded in 1988. The company specializes in FDA-cleared rapid testing solutions for dialysis centers, hospitals, surgery centers, and food production facilities. Core product lines include GUARDIAN® test strips for dialysis water quality and disinfectant monitoring, DISINTEK™ strips for high-level disinfectant verification in endoscopy and sterile processing, PINNACLE™ strips for cleaning validation in central service departments, MONITOR™ strips for food safety and sanitization applications, and PyloriTek® rapid urease tests for H. pylori detection. The company also provides custom test strip development, contract manufacturing, and private label solutions serving multiple industries including healthcare, food production, and laundry disinfection.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Mindset Medical is a digital health technology company that delivers an intelligent virtual health platform enabling intake, patient assessments, triage, and virtual exams through smartphone-based contactless video vital sign measurement. The platform uses patented remote photoplethysmography (rPPG) technology to transform standard device cameras into non-contact vital sign sensors, measuring heart rate, respiratory rate, and other physiological parameters without requiring traditional measurement devices or wearables. The solution includes real-time remote patient monitoring, precision health analytics, and API integration capabilities for seamless deployment across digital health ecosystems. Core features include edge-processing for privacy (video analysis occurs on-device with no transmission), end-to-end encryption, and FDA-cleared respiratory rate measurement functionality. Ideal for telehealth platforms, chronic disease management, post-acute care coordination, and integrated care delivery requiring continuous remote patient monitoring without hardware burden.

Etiometry, Inc. is a Boston-based medical technology company specializing in AI-driven clinical decision-support software for intensive care units (ICUs). The Etiometry Platform (T3 Platform) aggregates real-time patient data from bedside monitors, peripheral devices, and EHR systems into a unified dashboard powered by Bayesian models and proprietary AI algorithms. The platform computes personalized risk indices to enable proactive care management in both pediatric and adult critical care settings. Core features include data aggregation and visualization, risk analytics for hemodynamic and respiratory management, automated clinical pathway workflows aligned with hospital protocols, and quality improvement analytics. The platform has received 11 FDA 510(k) clearances and CE marking, and has been deployed across 150+ clinical studies leveraging 150+ million hours of de-identified patient data. Clinical evidence demonstrates up to 36% reduction in length of stay, 41% decrease in ICU readmissions, 30% reduction in mechanical ventilation time, and 29% shorter vasoactive infusion duration. Trusted by leading academic medical centers and top-ranked children's hospitals across North America, Europe, and Asia.